Darlene Got News Today

Been a true miracle. >> reporter: in 2014, i helped darlene get compassionate care usage of perjeta before it was approved by the fda. now doctors like dr. solomon of moffett cancer center use it as part of their standard care for breast cancer patients. an update of a study just released sunday shows the drug is adding an average 16 months to survival time. >> just to put it in perspective, generally were happy even if we see like a two to three-method increase in overall survival. thats why th...